Literature DB >> 17338151

Decreased systolic function and inadequate hypertrophy in large and small breed dogs with chronic mitral valve insufficiency.

Michele Borgarelli1, Alberto Tarducci, Renato Zanatta, Jens Haggstrom.   

Abstract

BACKGROUND: Systolic dysfunction associated with chronic mitral valve insufficiency (CMVI) has been demonstrated in experimental animal models and large breed (LB) dogs but has been reported as an uncommon finding in small breed (SB) dogs with naturally occurring disease. It has been suggested the myocardial failure could be, in part, because of an insufficient increase in left ventricular mass. HYPOTHESIS: To test if SB and LB dogs with CMVI and moderate heart failure have systolic dysfunction and if they have adequate eccentric hypertrophy. ANIMALS: Data from 38 SB and 18 LB dogs affected with CMVI were compared retrospectively with results from 2 groups of normal dogs (17 SB and 32 LB).
METHODS: Systolic function was investigated echocardiographically by using percentage fractional shortening (FS), the ratio between observed and expected end-systolic diameter (ESD/ESDe), and end-systolic volume index (ESVI). Left ventricular hypertrophy was estimated by using the ratio between the thickness of the left ventricular free wall and the radius in diastole (h/R).
RESULTS: Both affected SB and LB dogs had a significantly increased FS and ESVI (FS% SB 45.6 + 8.04 versus 40.06 + 8.9, P < .05; FS% LB 33.64 + 8.61 versus 27.3 + 7.3 P < .05; ESVI SB 30.0 +/- 2.3 mL/m2 versus 21.18 +/- 13.9 mL/m2, P < .05; ESVI LB 83.22 +/- 43.84 mL/m2 versus 36.43 +/- 13.30 mL/m2 versus P < .001). The h/R in affected animals was decreased (0.53 +/- 0.11 versus 0.41 +/- 0.12, P < .05 SB; 0.47 +/- 0.11 versus 0.38 +/- 0.09, P < .05, LB). CONCLUSIONS AND CLINICAL IMPORTANCE: Data from this study indicate that dogs with moderate heart failure caused by CMVI have systolic dysfunction. Inadequate hypertrophy of the left ventricle may be, in part, responsible for this finding.

Entities:  

Mesh:

Year:  2007        PMID: 17338151     DOI: 10.1892/0891-6640(2007)21[61:dsfaih]2.0.co;2

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  11 in total

1.  Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases.

Authors:  Eric de Madron; Jonathan N King; Günther Strehlau; Regina Valle White
Journal:  Can Vet J       Date:  2011-11       Impact factor: 1.008

2.  Evaluation of adverse reactions in dogs following intravenous mesenchymal stem cell transplantation.

Authors:  Min Hee Kang; Hee Myung Park
Journal:  Acta Vet Scand       Date:  2014-03-21       Impact factor: 1.695

3.  Serum proteomic profiles in CKCS with Mitral valve disease.

Authors:  Chiara Locatelli; Cristian Piras; Giulia Riscazzi; Isabella Alloggio; Ilaria Spalla; Alessio Soggiu; Viviana Greco; Luigi Bonizzi; Paola Roncada; Paola G Brambilla
Journal:  BMC Vet Res       Date:  2017-02-07       Impact factor: 2.741

4.  Markers of Oxidative Stress in Dogs with Myxomatous Mitral Valve Disease are Influenced by Sex, Neuter Status, and Serum Cholesterol Concentration.

Authors:  M J Reimann; J Häggström; J E Møller; J Lykkesfeldt; T Falk; L H Olsen
Journal:  J Vet Intern Med       Date:  2017-01-29       Impact factor: 3.333

5.  Prevalence and risk factors for atrial fibrillation in dogs with myxomatous mitral valve disease.

Authors:  Carlo Guglielmini; Marlos Goncalves Sousa; Marco Baron Toaldo; Carlotta Valente; Vinicius Bentivoglio; Chiara Mazzoldi; Ilaria Bergamin; Michele Drigo; Helen Poser
Journal:  J Vet Intern Med       Date:  2020-10-08       Impact factor: 3.333

6.  Comparison of Intestinal Microbiota Between Healthy and MMVD Chihuahuas Using 16S rRNA Gene Amplicon Sequencing.

Authors:  Ryuji Araki; Koji Iwanaga; Kazunori Ueda; Ayaka Shima; Genki Ishihara; Mitsuhiro Aizu; Toshiharu Fukayama; Mitsuhiro Isaka
Journal:  Front Vet Sci       Date:  2022-03-30

7.  Dobutamine stress echocardiography for assessment of systolic function in dogs with experimentally induced mitral regurgitation.

Authors:  R Suzuki; H Matsumoto; T Teshima; Y Mochizuki; H Koyama
Journal:  J Vet Intern Med       Date:  2014-01-16       Impact factor: 3.333

8.  Mitral Regurgitation Severity and Left Ventricular Systolic Dimension Predict Survival in Young Cavalier King Charles Spaniels.

Authors:  M J Reimann; J E Møller; J Häggström; T Martinussen; S S C Zatrazemi; L Svanholm; L B M Nielsen; H D Pedersen; L H Olsen
Journal:  J Vet Intern Med       Date:  2017-06-01       Impact factor: 3.333

Review 9.  Review of Diagnostic and Therapeutic Approach to Canine Myxomatous Mitral Valve Disease.

Authors:  Giulio Menciotti; Michele Borgarelli
Journal:  Vet Sci       Date:  2017-09-26

10.  Retrospective evaluation of hypertrophic cardiomyopathy in 68 dogs.

Authors:  Karsten E Schober; Phillip R Fox; Jonathan Abbott; Etienne Côté; Virginia Luis-Fuentes; Jose Novo Matos; Joshua A Stern; Lance Visser; Katherine F Scollan; Valerie Chetboul; Donald Schrope; Tony Glaus; Roberto Santilli; Romain Pariaut; Rebecca Stepien; Vanessa Arqued-Soubeyran; Marco Baron Toaldo; Amara Estrada; Kristin MacDonald; Emily T Karlin; John Rush
Journal:  J Vet Intern Med       Date:  2022-03-24       Impact factor: 3.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.